Apr 10, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.15 to $0.01.
The split itself did not change the total investment value.
TRACON Pharmaceuticals, Inc. (TCON) trades on the Other OTC in the Biotechnology industry.
TRACON Pharmaceuticals, Inc. company overviewThe latest split shown was on April 10, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between November 8, 2019 and April 10, 2024.